OrphoMed Secures $2,816,012 New Funding Round

  • Feed Type
  • Date
    1/18/2016
  • Company Name
    OrphoMed
  • Mailing Address
    806 Denise Court Mill Valley, CA 94941 USA
  • Company Description
    OrphoMed is a San Francisco Bay Area pharmaceutical company focused on the development of novel first-in-class therapeutic dimer conjugates based on its proprietary DIMERx platform technology.
  • Website
    http://www.orphomed.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,816,012
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 10 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed